Archive for February, 2013

BiovaFlex® Raises Egg Membrane Protein Standard to 88 Percent

Johnston, Iowa, USA (February 28, 2013) — Biova® LLC, developer of patented Hydro5™ technology for water-soluble egg membrane, has increased the standardized protein profile of its BiovaFlex® ingredient to what it believes is a market-leading 88 percent.

“The science indicates bioactivity is tied to the natural, non-denatured egg membrane matrix,” said Matt Stegenga, Biova director of marketing. “The primary composition of this matrix is a natural ratio of complex proteins including glycosaminoglycans, collagen, elastin, desmosine, isodesmosine and transforming growth factor. So yes, hitting uniform 88 percent protein across all BiovaFlex production is significant for us because it’s important for our customers’ products.”

Continue Reading

© 2017 Biova® LLC | Privacy Policy

* These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.

** Details available upon request